Similarly, Bcl-2 is also an anti-apoptotic protein that inhibits programmed cell death (73) and is believed to play an important role in cell survival and drug resistance of lymphomas, colorectal cancer, prostate cancer, and other malignancies (74). Here, BCL2 is linked to prostate cancer.